Intramuscular Diphenhydramine Administration

Clinical Context and Recommendations

Parenteral antihistamines, including intramuscular diphenhydramine, are recommended for treating allergic reactions when rapid intervention is needed or oral administration is not feasible, according to the Journal of Allergy and Clinical Immunology guidelines 1
In anaphylaxis treatment protocols, diphenhydramine serves as an adjunctive medication, not first-line therapy, with epinephrine remaining the essential first-line treatment 2
The American Academy of Allergy, Asthma, and Immunology recommends diphenhydramine (1-2 mg/kg or 25-50 mg parenterally) be administered after epinephrine for treating allergic reactions 3
Combined H1 and H2 antagonist therapy (diphenhydramine plus ranitidine) is superior to H1 antagonists alone in treating allergic reactions, as suggested by the Journal of Allergy and Clinical Immunology and Annals of Oncology 3, 4, 5

For parenteral administration in allergic reactions, the recommended dose of diphenhydramine is 1-2 mg/kg or 25-50 mg (parenterally via IM or IV), according to the Journal of Allergy and Clinical Immunology 3
Diphenhydramine should be combined with ranitidine (1 mg/kg diluted in D5W, given IV over 5 minutes) for optimal effect in treating allergic reactions 3

Never delay epinephrine administration to give diphenhydramine in anaphylaxis, as this is associated with poor outcomes and fatality, as warned by Praxis Medical Insights 2
Do not substitute antihistamines for epinephrine as first-line treatment in anaphylaxis, as emphasized by Praxis Medical Insights 2